FDA review confirms safety, efficacy of single-shot Johnson & Johnson coronavirus vaccine, especially against severe cases

The review sets the stage for a third coronavirus vaccine to be authorized as soon as this weekend, a point of hope in the middle of a pandemic that has killed more than a half-million people in the United States.

View original article
Contributor: Carolyn Y. Johnson